Using microarray gene expression analysis, we have preliminary evidence demonstrating highly significant inhibition of a number of genes involved in the IL-6/STAT-3 pathway (such as IL-6ST, IL-6R, and SOCS3) in MH-treated human breast cancer cells (al-Ramadi et al., unpublished observations). The gene discussed is STAT3; the disease is breast cancer.